Want to join the conversation?
Jeffrey Bernstein of Barclays asks about the full recovery and how much time it will take for $CMG to recover. Co-CEO Steven Ells stated that $CMG is not able to predict the time frame for full recovery. He added that the situation has been challenging and frustrating. $CMG's objective is to fully win all of its customers back.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.